@prefix c0x: <http://data.loterre.fr/ark:/67375/C0X> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix dc11: <http://purl.org/dc/elements/1.1/> .

c0x:-JLN9396V-K
  skos:broader c0x:-CP2C27NL-M ;
  skos:altLabel "AstraZeneca plc"@en, "AstraZeneca plc"@fr ;
  skos:definition "AstraZeneca plc is a British-Swedish multinational pharmaceutical and biopharmaceutical company with its headquarters in Cambridge, England. AstraZeneca has a portfolio of products for major disease areas including cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation. (Wikipédia)"@en, "AstraZeneca est un groupe pharmaceutique, né de la fusion en avril 1999 du suédois Astra et de l'anglais Zeneca. (Wikipédia)"@fr ;
  a skos:Concept ;
  dc:created "2020-12-08"^^xsd:date ;
  skos:exactMatch <https://fr.wikipedia.org/wiki/AstraZeneca>, <https://en.wikipedia.org/wiki/AstraZeneca> ;
  skos:related c0x:-SPWFRSGR-N ;
  dc11:creator "Patricia Fener" ;
  skos:prefLabel "AstraZeneca"@en, "AstraZeneca"@fr ;
  skos:inScheme c0x: ;
  dc:modified "2020-12-16"^^xsd:date .

c0x: a skos:ConceptScheme .
c0x:-SPWFRSGR-N
  skos:prefLabel "ChAdOx1 nCoV-19"@en, "ChAdOx1 nCoV-19"@fr ;
  a skos:Concept ;
  skos:related c0x:-JLN9396V-K .

c0x:-CP2C27NL-M
  skos:prefLabel "UK pharmaceutical laboratory"@en, "laboratoire pharmaceutique britannique"@fr ;
  a skos:Concept ;
  skos:narrower c0x:-JLN9396V-K .